Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical · Travel Services

Norwegian Cruise Line Holdings

NCLH · a US exchange · USD · Market cap $8.6B · 44,500 employees

Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally.

FAIL · Does not pass the screen
17.99 USD

Price as of 18 Nov 2026Daily close, not a live quote

Screened 2026-11-18 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price17.99 USD at the 18 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 18 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.38)
  • Last reviewed18 Nov 2026 (2 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $11.70 to $18.58, base estimate $16.15 (screen dated 2026-11-18).

Current read
Markup ?
Overvalued · screened 2026-11-18
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning political buying, disclosed 2026-10-20
  • Options put/call open interest 0.38, read 2026-11-18
  • Ethical does not pass the values gate
Price17.99 USD
Fair value16.15
Ethical score10.0/100
Value readOvervaluedas of 18 Nov 2026
Our investment reviews on this name
2026-11-05Read Markup18.60-3.3% to today Accumulation gives way to Markup after a 26% rise in 4 weeks
2026-10-11Read Accumulation14.80+21.6% to today ✓Markdown gives way to Accumulation after a 14% slide in 5 weeks
2026-09-06Read Markdown17.22+4.5% to today Markup gives way to Markdown after an 8% slide in 4 weeks
2026-08-06Read Markup18.72-3.9% to today Distribution gives way to Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Norwegian Cruise Line Holdings holds its Markup at $17.99. The statistical read favours the sellers, held for 15 days.

As held on the ledger · 2026-11-18
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 15 days
Price at the screen$17.99
Valuation10.40 trailing · 13.23 forward price to earnings
Values screenFAIL · score 10.0
Beta1.96
The Workings

Five Screens: NCLH's Results

FAIL. Debt ratio

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 64.80% Below 33% Fail
Interest-bearing cash 0.00% Below 33% Pass
Receivables 2.23% Below 49% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Falls Short, in Plain English

Norwegian Cruise Line's business is in a permissible area, but its interest-bearing debt is about 65% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when NCLH's ethical verdict changes

Today NCLH does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 18 Nov 2026: it trades above our $16.15 fair value estimate, narrow competitive moat, 0.30% revenue growth.

Model construction and limits: fair-value methodology.

11.70Conservative16.15Base case18.58Growth case 17.99Price

Fair value range in USD, drawn from the 2026-11-18 screen. The gold marker is the market price at the same screen. The price runs 11.4% above the base estimate.

The Street's Range
13.00Street low 19.50Street average 26.00Street high 17.99Price

Third-party analyst targets: 24 covering, consensus Buy. The average target sits +8% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $16.15, with a range of $11.70 to $18.58, dated to the 2026-11-18 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words

Cruise line's cheap price hides heavy debt

Picture a packed ship leaving port with the hull already taking on water. Norwegian Cruise Line shows solid revenue growth and a 30 percent return on equity, yet the business carries debt levels that trip our ethical screen outright. That leaves little room for the unexpected storms the sector faces every cycle.

The narrow moat and 9.6 times forward earnings create the look of value, but this is exactly the cyclical trap where peak earnings meet a low multiple. Revenue expansion at 10 percent and thin 6 percent margins offer scant buffer once bookings soften, and the ethical debt failure rules the name out regardless of analyst targets.

Consensus buy ratings ignore the structural leverage that remains after the pandemic. Any fresh slowdown in travel demand would expose how little protection sits beneath those headline numbers.

Analysis, not advice.

The fundamentals · plain-English read
Forward P/E13.2xexpensive even after accounting for its growth
Trailing P/E10.4xreasonably valued
EPS, trailing1.81
EPS, forward1.42
Revenue growth+0.3%slow but positive growth
Profit margin8.2%thin but positive margins
Return on equity31.2%an exceptional return on shareholder capital
FCF yield-12.11%
Debt to equity5.09heavy leverage: higher risk if revenue softens
Current ratio0.23below 1: short-term bills exceed liquid assets
Beta1.96much more volatile than the market
Short interest, float0.20%
52-week range13.63 - 25.13
MoatNARROW
Market cap$8.6B
Employees44,500

NCLH-specific watchpoints · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-19 Markup $17.99 -4.4% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $20.

2026-11-12 Markup $18.82 +1.2% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $20.

2026-11-05 Markup · changed $18.60 +23.2% Entry 17

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 23.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (23 analysts) rates it buy, with a mean price target of $20.

2026-10-29 Accumulation $15.10 -0.9% Entry 16

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Accumulation $15.24 +0.0% Entry 15

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Accumulation $15.24 +0.0% Entry 14

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Accumulation $15.24 +0.0% Entry 13

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Accumulation $15.24 +0.0% Entry 12

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Accumulation $15.24 +0.0% Entry 11

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Accumulation $15.24 +0.0% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (24 analysts) rates it buy, with a mean price target of $19. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on NCLH

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in NCLH's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · NCLH
DateInsiderTitleTypeSharesValue
2026-05-19 CIL JOSE E Director 15,000 $225,350
2026-05-11 MACDONALD BRIAN P Director 15,000 $248,100
2026-05-07 BYNG-THORNE ZILLAH Director 29,467 $521,394
2026-05-07 LANSBERRY KEVIN ALLEN Director 11,400 $196,992
2026-04-13 MACDONALD BRIAN P Director 8,912 ·
2026-04-13 PAGLIUCA STEPHEN G Director 8,912 ·
2026-04-13 COHEN JONATHAN Z Director 8,912 ·
2026-04-13 CRUZ ALEX Director 8,912 ·
2026-04-13 LANSBERRY KEVIN ALLEN Director 8,912 ·
2026-03-26 CHIDSEY JOHN W Chief Executive Officer 967,254 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming NCLH
DatePoliticianPartyTypeAmount
2026-10-20 Gil Cisneros Democrat buy 1K–15K
2026-10-13 Ro Khanna Democrat buy 1K–15K
2025-02-07 Tim Walberg Republican buy 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $15.24 +18.0% · $1,180 +18.0%
2 months $14.12 +27.4% · $1,274 +27.4%
3 months $16.75 +7.4% · $1,074 +7.4%
6 months $16.30 +10.4% · $1,104 +10.4%
1 year $17.84 +0.8% · $1,008 +0.8%
2 years $26.10 -31.1% · $689 -31.1%
3 years $14.93 +20.5% · $1,205 +20.5%
5 years $23.09 -22.1% · $779 -22.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever NCLH does next, these words stay.

Norwegian Cruise Line Holdings · NCLH · Markup · $17.99
Recorded 2026-11-18 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.